Comment: assessing humoral immunocompetence after alemtuzumab treatment in MS.
Anne H
AH
Cross
Robyn S
RS
Klein
D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007121:Immunocompetence / Q000276:immunology*; D008297:Male; D009103:Multiple Sclerosis / Q000276:immunology* / Q000628:therapy*
D061067:Antibodies, Monoclonal, Humanized; D000074323:Alemtuzumab